From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection

Circulation Research
Paul M Ridker

Abstract

Plasma levels of the inflammatory biomarker high-sensitivity C-reactive protein (hsCRP) predict vascular risk with an effect estimate as large as that of total or high-density lipoprotein cholesterol. Further, randomized trial data addressing hsCRP have been central to understanding the anti-inflammatory effects of statin therapy and have consistently demonstrated on-treatment hsCRP levels to be as powerful a predictor of residual cardiovascular risk as on-treatment levels of low-density lipoprotein cholesterol. Yet, although hsCRP is clinically useful as a biomarker for risk prediction, most mechanistic studies suggest that CRP itself is unlikely to be a target for intervention. Moving upstream in the inflammatory cascade from CRP to interleukin (IL)-6 to IL-1 provides novel therapeutic opportunities for atheroprotection that focus on the central IL-6 signaling system and ultimately on inhibition of the IL-1β-producing NOD-like receptor family pyrin domain containing 3 inflammasome. Cholesterol crystals, neutrophil extracellular traps, atheroprone flow, and local tissue hypoxia activate the NOD-like receptor family pyrin domain containing 3 inflammasome. As such, a unifying concept of hsCRP as a downstream surrogate biomarker ...Continue Reading

Citations

Jun 25, 2016·Oxidative Medicine and Cellular Longevity·Francesco PrattichizzoAntonio Ceriello
Jul 1, 2016·Future Medicinal Chemistry·Joe We Moss, Dipak P Ramji
Jul 8, 2016·Nature Reviews. Cardiology·Joe W E Moss, Dipak P Ramji
Aug 17, 2016·International Journal of Molecular Sciences·Miguel Ruiz-CanelaMiguel A Martínez-González
Sep 7, 2016·Molecular Aspects of Medicine·Per Magne UelandArve Ulvik
Oct 5, 2016·Postgraduate Medicine·Pavlina A Andreeva-GatevaIscra Simova
Apr 4, 2017·British Journal of Pharmacology·Alberico Luigi CatapanoGiuseppe Danilo Norata
Dec 17, 2016·Molecular Nutrition & Food Research·Nitin ShivappaInge Huybrechts
May 6, 2017·Interactive Cardiovascular and Thoracic Surgery·Se Jin OhKi-Bong Kim
Nov 26, 2016·Clinics in Geriatric Medicine·Rachel H MackeyLarry W Moreland
Dec 23, 2016·Journal of the American College of Cardiology·Jacob F Bentzon
Apr 19, 2017·Pain·Elina Iordanova SchistadChristopher Sivert Nielsen
Jun 24, 2017·Journal of the American College of Cardiology·Alison KearnsXuebin Qin
Dec 15, 2016·Antioxidants & Redox Signaling·Pedro BullónMario D Cordero
Jun 15, 2017·Journal of Molecular Endocrinology·Thalijn Liliana Catharina WoltersRomana Teodora Netea-Maier
Jun 22, 2017·European Heart Journal. Cardiovascular Pharmacotherapy·Leo F BuckleyAntonio Abbate
Nov 3, 2017·Medicine·Christiana SchernthanerDaniel Kretzschmar
Jul 23, 2016·International Journal of Molecular Sciences·Xiaojuan Ma, Yingmei Feng
Jan 26, 2018·Journal of Cardiovascular Development and Disease·Nathan A HollandDavid A Tulis
Jan 11, 2018·International Journal of Environmental Research and Public Health·Pieter H MyburghCornelie Nienaber-Rousseau
Mar 31, 2018·Journal of Leukocyte Biology·Laura D HealyOwen J T McCarty
Apr 19, 2018·Journal of Dietary Supplements·Mark F McCartyJames J DiNicolantonio
May 4, 2018·European Journal of Preventive Cardiology·Elin Good, Ebo de Muinck
Sep 22, 2017·Current Cardiology Reports·Petra H Wirtz, Roland von Känel
Sep 29, 2017·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Lauren K StewartJeffrey A Kline
Dec 1, 2017·The Journal of Physiological Sciences : JPS·Maria Guadalupe Soares AmorimElaine Hatanaka
Feb 13, 2018·Mediators of Inflammation·Arduino A MangoniGian Luca Erre
Jan 10, 2018·Frontiers in Cardiovascular Medicine·Koji AkitaHiroyuki Daida
Sep 8, 2017·Alimentary Pharmacology & Therapeutics·A Ponzetto, N Figura
Aug 2, 2018·Nature Reviews. Cardiology·Luigi Ferrucci, Elisa Fabbri
Jul 12, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H HashimotoK Yamamoto
Aug 17, 2018·PloS One·Hilary M DuBrockMargaret M Redfield
May 19, 2018·Journal of the American Heart Association·Agnethe EltoftStein Harald Johnsen
Sep 21, 2018·Expert Review of Endocrinology & Metabolism·William P MartinCarel W Le Roux
Aug 27, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Toshiaki NakanoMasanori Aikawa
Dec 9, 2017·Circulation Research·Borja Ibañez, Valentin Fuster
Apr 22, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Christian HerderBarbara Thorand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.